Precision BioSciences Inc Reacquires Global Rights to its Allogeneic CAR T Programs- Conference Call Transcript
Good day and thank you for standing by. Welcome to the Precision Regains Global Commercial Rights to CAR T Programs Conference Call. (Operator Instructions). Please be advised that today's conference is being recorded. (Operator Instructions). I would now like to hand the conference over to your speaker today, Alex Kelly, Interim Chief Financial Officer and Corporate Affairs Officer. Please go ahead.
Thank you, Gigi. And good afternoon, everyone, and welcome to our webcast to discuss our agreement with Servier to reacquire rights to our CAR T programs.
Before we begin, I would like to remind you that the statements we make today on this webcast do not relate to matters of historical fact or future -- [or our] future expectations and forward-looking statements.
Our forward-looking statements are within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |